Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceGut health

Spore-Based Probiotics (Bacillus)

Bacillus spores survive stomach acid and shelf storage far better than Lactobacillus, which is a genuine formulation advantage — but the clinical evidence is thin, dominated by small manufacturer-run trials, and does not yet justify the premium price or the 'soil-based, superior' marketing.

What the science says

  • Improves IBS symptoms Limited evidence

    A 90-day RCT of Bacillus coagulans Unique IS2 (2 billion CFU/day, n=100) reported significant reductions in abdominal pain and bloating versus placebo, and other small B. coagulans trials point the same way. But nearly all are single-centre, manufacturer-funded, and small; network meta-analyses of probiotics in IBS do not identify Bacillus strains as superior to better-studied alternatives.

  • Reduces gas and bloating in healthy adults Limited evidence

    A randomised, double-blind trial of Bacillus subtilis BS50 (n=99) found reductions in self-reported gas and bloating over 6 weeks, and a B. coagulans MTCC 5856 trial reported similar results. Effects were on subjective questionnaires in generally healthy people, short in duration, and industry-sponsored — hypothesis-generating rather than established.

  • Survives gastric acid better than lactobacilli Moderate evidence

    This is a well-supported microbiological fact: endospores tolerate gastric acid, bile and ambient-temperature storage, so labelled CFU counts are more likely to be delivered alive. It is a real advantage for shelf stability, but survival is not the same as clinical benefit — a strain still has to be shown to do something once it arrives.

  • Repairs 'leaky gut' or reduces endotoxaemia Limited evidence

    A single small trial reported reduced post-meal endotoxin levels with a Bacillus blend. One small study with a surrogate biomarker is not a basis for the leaky-gut claims used to sell these products; there is no RCT evidence of clinical outcomes following improved barrier markers.

Dosage & safety

Studied doseTrials have used 1-6 billion CFU/day, typically for 4-12 weeks — far lower than the 50-100 billion CFU counts common in Lactobacillus products, because spores survive transit. B. coagulans Unique IS2: 2 billion CFU/day. B. subtilis BS50: 1 billion CFU/day. Take with food; no refrigeration needed.
SafetyGenerally well tolerated, with transient gas and loose stools in the first week. Not all Bacillus species are equivalent: B. cereus produces emetic and diarrhoeal toxins, and contamination of probiotic products with toxigenic strains has been documented — only use products naming a specific, characterised strain. Some Bacillus strains carry transferable antibiotic-resistance genes, a recognised regulatory concern for the genus. Avoid in immunocompromised individuals, those with central lines, and critically ill patients; Bacillus bacteraemia from probiotics has been reported. B. coagulans is frequently mislabelled 'Lactobacillus sporogenes' — a name that is not taxonomically valid and a marker of a low-quality product.

Scientific references

Where to buy

Youtheory, Spore Probiotic + Triphala Blend, 60 Vegetarian Capsules

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Gut health